JAMP METHOTREXATE TABLETS DIN 02553740
Health Canada record
| Active ingredient(s) | METHOTREXATE 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01BA01 METHOTREXATE |
| Original market date | 10-Jun-2025 |
| Current status date | 10-Jun-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHOTREXATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02448165 | AURO-METHOTREXATE TABLETS | AURO PHARMA INC | Tablet | METHOTREXATE 10 MG | Approved |
| 02182750 | METHOTREXATE TABLETS, USP | PFIZER CANADA ULC | Tablet | METHOTREXATE 10 MG | Marketed |
| 02561956 | PMS-METHOTREXATE TABLETS | PHARMASCIENCE INC | Tablet | METHOTREXATE 10 MG | Marketed |
| 02170671 | METHOTREXATE | PFIZER CANADA ULC | Solution | METHOTREXATE 25 MG | Cancelled Post Market |
| 00014915 | METHOTREXATE TAB 2.5MG | LEDERLE CYANAMID CANADA INC. | Tablet | METHOTREXATE 2.5 MG | Cancelled Post Market |
| 00632619 | METHOTREXATE TAB 2.5MG USP | DAVID BULL LABORATORIES (PTY) LTD. | Tablet | METHOTREXATE 2.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34483 | 2024-12-04 | Abbreviated New Drug Submission (ANDS) |
International API supply for METHOTREXATE
6 valid EDQM Certificates of Suitability from 6 holders. 15 active FDA Drug Master Files.
Request a quote for JAMP METHOTREXATE TABLETS